Bernard J. Zovighian - 03 May 2022 Form 3/A - Amendment Insider Report for Edwards Lifesciences Corp (EW)

Role
CEO, Director
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
03 May 2022
Net transactions value
$0
Form type
3/A - Amendment
Filing time
05 Feb 2025, 19:46:01 UTC
Date Of Original Report
05 May 2022
Next filing
10 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EW Common Stock 22,291 03 May 2022 Direct
holding EW Common Stock 15,135 03 May 2022 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were previously misclassified from the reporting person's original Form 3 as directly held but were, in fact, indirectly held through the reporting person's trust and were misclassified from each of the Forms 4 filed by the reporting person after his original Form 3 was filed.